Kamagra Oral Jelly is an innovative formulation containing:
- Sildenafil Citrate (50-100mg): PDE5 inhibitor
- Gel-based delivery system for rapid absorption
- Equivalent efficacy to conventional Viagra®
Key Benefits:
- Faster onset than tablets (30-120 minutes)
- 4-6 hour duration of effect
- Ideal for patients with swallowing difficulties
- Multiple flavor options available
Dosage & Administration
- Standard starting dose: 50mg (one sachet)
- Dose adjustment:
- May increase to 100mg if needed
- May decrease to 25mg for tolerability
- Administration:
- Consume contents directly from sachet
- No water required
- Optimal timing: 1 hour before sexual activity
- Maximum frequency: Once per 24 hours
Critical Safety Information
Absolute Contraindications:
- Nitrate therapy (including recreational poppers)
- Recent cardiovascular events (<6 months)
- Uncontrolled hypertension/hypotension
- Hereditary retinal disorders (retinitis pigmentosa)
- Severe hepatic impairment
Drug Interactions:
Contraindicated:
- All nitrate medications
- Other PDE5 inhibitors
- Strong CYP3A4 inhibitors:
- Erythromycin
- Ketoconazole
- Ritonavir
- Itraconazole
Require caution:
- Alpha-blockers
- Antihypertensives
- Grapefruit products
Potential Adverse Effects
Common (transient):
- Headache (16%)
- Facial flushing (12%)
- Nasal congestion (6%)
- Dyspepsia (5%)
- Visual disturbances (3%)
Serious (require immediate medical attention):
- Priapism (>4 hours)
- Sudden vision/hearing loss
- Cardiovascular events
- Severe hypotension
- Allergic reactions
Patient Counseling Points
- Sexual stimulation required for effect
- Avoid:
- High-fat meals before use
- Excessive alcohol consumption
- Grapefruit products
- Report immediately:
- Erections >4 hours
- Chest pain during activity
- Sudden sensory changes
- Storage:
- Room temperature (15-30°C)
- Protect from heat/moisture
- Keep away from children
Note: This medication requires prescription and medical supervision. Counterfeit products may be dangerous - obtain only from licensed pharmacies. Not for use in women or pediatric populations. Regular cardiovascular monitoring recommended for high-risk patients.